CS
REGN icon

Comerica Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Comerica Securities’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-283
Closed -$233K – 490
2023
Q1 		$233K Sell
283
-2
-0.7% -$1.51K 0.02% 429
2022
Q4 		$206K Buy
+285
New +$210K 0.01% 467
2022
Q1 		– Sell
-510
Closed -$322K – 523
2021
Q4 		$322K Sell
510
-46
-8% -$28.3K 0.02% 406
2021
Q3 		$336K Sell
556
-163
-23% -$101K 0.02% 383
2021
Q2 		$402K Sell
719
-104
-13% -$52.7K 0.03% 347
2021
Q1 		$389K Buy
823
+374
+83% +$182K 0.03% 361
2020
Q4 		$217K Buy
+449
New +$242K 0.02% 457
2020
Q3 		– Sell
-1,276
Closed -$796K – 464
2020
Q2 		$796K Buy
+1,276
New +$724K 0.08% 208
2019
Q1 		– Sell
-988
Closed -$369K – 442
2018
Q4 		$369K Sell
988
-28
-3% -$10.2K 0.05% 291
2018
Q3 		$411K Buy
1,016
+27
+3% +$10.3K 0.05% 303
2018
Q2 		$341K Buy
989
+38
+4% +$11.9K 0.04% 320
2018
Q1 		$327K Buy
951
+68
+8% +$23.7K 0.04% 317
2017
Q4 		$332K Buy
883
+11
+1% +$4.46K 0.04% 317
2017
Q3 		$390K Buy
872
+211
+32% +$100K 0.05% 288
2017
Q2 		$325K Buy
661
+112
+20% +$49K 0.05% 302
2017
Q1 		$213K Buy
+549
New +$203K 0.03% 361
2016
Q1 		– Sell
-806
Closed -$438K – 371
2015
Q4 		$438K Sell
806
-7
-0.9% -$3.79K 0.11% 217
2015
Q3 		$378K Buy
813
+20
+3% +$10.7K 0.1% 201
2015
Q2 		$405K Buy
+793
New +$387K 0.1% 212

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Comerica Securities's REGN Position: Q2 2023 in Review

Comerica Securities sold out of Regeneron Pharmaceuticals (REGN) in Q2 2023, closing a stake of 283 shares — an estimated $233K sold.

Comerica Securities first reported a position in REGN in Q2 2015 and held it in 19 quarters. The position peaked at $796K in Q2 2020. 1,164 funds tracked by Wall St. Rank hold REGN as of Q2 2023.

  • Comerica Securities reported no remaining Regeneron Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Comerica Securities sold 283 Regeneron Pharmaceuticals shares in Q2 2023, an estimated $233K.
  • Comerica Securities first reported a position in Regeneron Pharmaceuticals in Q2 2015 and held it in 19 quarters.
  • Comerica Securities's Regeneron Pharmaceuticals position peaked at $796K in Q2 2020.
  • 1,164 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2023.

Based on Comerica Securities's 13F filing for Q2 2023, filed 4 Aug 2023.